chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Pneumonia, Pulmonary embolism, Scan myocardial perfusion, Suspected COVID-19
Clinical narrative: Covid; Covid; Pericarditis; Pulmonary Embolisms in both lungs; DVT in right calf; pneumonia; A Fib; I have asthma which has gotten extremely worse after Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "I have asthma" (unspecified if ongoing), notes: I have asthma which has gotten extremely worse after Covid. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Covid"; PERICARDITIS (medically significant), outcome "unknown"; PULMONARY EMBOLISM (medically significant), outcome "unknown", described as "Pulmonary Embolisms in both lungs"; DEEP VEIN THROMBOSIS (medically significant), outcome "unknown", described as "DVT in right calf"; PNEUMONIA (medically significant), outcome "unknown"; ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "A Fib"; ASTHMA (non-serious), outcome "unknown", described as "I have asthma which has gotten extremely worse after Covid". The patient underwent the following laboratory tests and procedures: Scan myocardial perfusion: failed.  Clinical course: Patient had complications due to Covid. Pericarditis, Pulmonary Embolisms in both lungs, DVT in right calf, and rare pneumonia that Covid causes. I had all shots. My health was very poor. I also went from NSR into A Fib. I have asthma which has gotten extremely worse after Covid. I failed a Nuclear Stress test. Medical Information  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Medication error, No adverse event, Single component of a two-component product administered
Clinical narrative: received only the diluent part of PENTACEL and not the powder with no reported adverse event; Initial information was received  on 17-May-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 4 years old male patient who reported received only the diluent part of Pentacel and not the powder with no reported adverse event after receiving diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine [Pentacel (VERO)].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included measles vaccine, MUMPS VACCINE, rubella vaccine (MMR) for Immunisation; and VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for Immunisation.  On 11-May-2023, the patient received 0.5 ml, total (once) dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine Suspension for injection (lot:UJ786AA, expiration date:12-Oct-2023, strength: standard) via intramuscular route in the left thigh for Immunization.  On 11-May-2023 the patient had received only the diluent part of Pentacel and not the powder with no reported adverse event (Single component of a two-component product administered) same day following the administration of diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event administration of the pentacel components separately with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: pentacel product expired on 5/4, but was administered on 5/17 with no reported adverse event; Initial information received on 18-May-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 4 years old male patient who was administered expired DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] vaccine which expired on 04-May-2023, but was administered on 17-May-2023 with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD) and HEPATITIS A VACCINE (HEPATITIS A VACCINE) both for Prophylactic vaccination (Immunization).  On 17-May-2023, the patient received a dose of 0.5 ml once of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE (Suspension for injection) (lot: UJ662AA; expiry date: 04-MAY-2023; strength: standard) via intramuscular route in unknown administration site for Immunization.  On 17-May-2023 the patient was administered expired pentacel vaccine which expired on 04-May-2023 with no reported adverse event (expired product administered) (latency: same day).  It was reported, "Caller wanted to know if patient need to be re-vaccinated."  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Autoimmune disorder, Echocardiogram, Pericarditis
Clinical narrative: Pericarditis. Autoimmune response
Sex: U
Vaccine: COVID19-2
Symptoms: Blood pressure measurement, Hypertension, Vaccination site pain
Clinical narrative: blood pressure was high; The arm they gave me the shot in is sore; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (The arm they gave me the shot in is sore) and HYPERTENSION (blood pressure was high) in a 0-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     Patient took blood pressure medicine.     On 16-May-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-May-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced VACCINATION SITE PAIN (The arm they gave me the shot in is sore). On an unknown date, the patient experienced HYPERTENSION (blood pressure was high). At the time of the report, VACCINATION SITE PAIN (The arm they gave me the shot in is sore) had not resolved and HYPERTENSION (blood pressure was high) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: High  196/101.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Treatment medication not reported.
Sex: U
Vaccine: UNK
Symptoms: Medication error, No adverse event, Product preparation error
Clinical narrative: medication error due to PENTACEL was not reconstituted correctly before administration to a patient with no reported adverse event; Initial information received on 17-May-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced medication error due to Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (Vero)] was not reconstituted correctly before administration with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose 1 of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) vaccine suspension for injection with unknown batch number, strength & expiry date via unknown route in unknown administration site for Prophylactic vaccination. Information on the batch number was requested.  On an unknown date the patient developed a non-serious event "medication error due to pentacel was not reconstituted correctly before administration to a patient with no reported adverse event" (product preparation issue) (unknown latency) following the administration of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) vaccine.  It was reported that "This situation is reported as a medication error due to PENTACEL was not reconstituted correctly before administration to a patient. This is reported as a medication error; they report that a patient received PENTACEL, but they only received the liquid DTaP-IPV portion; it was not reconstituted with the powdered HIB portion. The physician notes that this error with PENTACEL was made 2 months ago, and it was the patient's 1st dose in the PENTACEL series. The physician also reports that the patient was recently in the office again for their well-visit, and the patient received the 2nd dose in the PENTACEL series; the physician confirms that the 2nd dose of the PENTACEL series was reconstituted correctly".  Action taken: not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 41.0
Sex: U
Vaccine: HPV9
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE; expired dose of GARDASIL-9; This spontaneous report was received from a pharmacist referring to a 41-year-old patient of unknown gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On 17-MAY-2023, the patient was vaccinated with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection (0.5 ml/ once, lot#: U007652, expiration date: 14-APR-2023; route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse event (AE) was reported (no adverse event).
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Pain at injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18-MAY-2023, the patient received the 2nd dose of Shingrix. On 18-MAY-2023, less than a day after receiving Shingrix, the patient experienced injection site pain (Verbatim: Pain at injection site). The outcome of the injection site pain was not resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.     It was unknown if the company considered the injection site pain to be related to Shingrix.   Additional Information: GSK receipt date: 18-MAY-2023 The patient experienced pain at injection site after receiving dose of Shingrix. The reporter did not consent to follow up.
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: 9 doses were administered post excursion; Product storage error; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (9 doses were administered post excursion), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event) in an infant patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (9 doses were administered post excursion), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (9 doses were administered post excursion), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (9 doses were administered post excursion) and PRODUCT STORAGE ERROR (Product storage error).    No concomitant medications were reported. Storage condition at the time of the excursion was frozen. Temperature noted in that condition was -2 to -18 C. Excursion duration was for 2hrs. The vial belongs to one of the following batch numbers AR9236B, Exp date: 22-Aug-2023 / AS1903B, Exp date: 14-Jun-2023 / AS7170B, Exp date: 09-Jun-2023.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2023: Live Significant follow-up received: New events added and Narrative was updated
Sex: F
Vaccine: COVID19-2
Symptoms: Brain fog, Dizziness, Dysstasia, Erythema, Fatigue
Clinical narrative: redness; had brain fog; alike an unclear head; difficult to stand; dizziness; tiredness; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (redness), BRAIN FOG (had brain fog), HEAD DISCOMFORT (alike an unclear head), DYSSTASIA (difficult to stand) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dizziness and Rheumatic fever.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness), BRAIN FOG (had brain fog), HEAD DISCOMFORT (alike an unclear head), DYSSTASIA (difficult to stand), DIZZINESS (dizziness) and FATIGUE (tiredness). At the time of the report, ERYTHEMA (redness), DIZZINESS (dizziness) and FATIGUE (tiredness) had not resolved and BRAIN FOG (had brain fog), HEAD DISCOMFORT (alike an unclear head) and DYSSTASIA (difficult to stand) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported. It is unknown when her most recent dose was or how many doses she had received. She was unsure if her most recent dose was a monovalent or bivalent product. Since she had the last shot she had brain fog. This is alike an unclear head. It's very hard to get rid of if at all. Had a problem with dizziness regularly that had been ongoing since before the vaccine. The dizziness coupled with the brain fog can make it difficult to stand. Drinking ginger dissolved in boiling water seems to help with the brain fog. She had also been having some issues with tiredness and redness. She was told prior to receiving her most recent vaccine she should not receive it because of her continued dizziness symptoms. She received this dose anyways. She just spoke with her pharmacist who was concerned that her symptoms had lasted so long. Unknown how long after receiving this dose symptoms started. Unknown how long symptoms had been ongoing. She never had covid. History of rheumatic fever.
Sex: F
Vaccine: COVID19-2
Symptoms: Head discomfort
Clinical narrative: redness; had brain fog; alike an unclear head; difficult to stand; dizziness; tiredness; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (redness), BRAIN FOG (had brain fog), HEAD DISCOMFORT (alike an unclear head), DYSSTASIA (difficult to stand) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dizziness and Rheumatic fever.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness), BRAIN FOG (had brain fog), HEAD DISCOMFORT (alike an unclear head), DYSSTASIA (difficult to stand), DIZZINESS (dizziness) and FATIGUE (tiredness). At the time of the report, ERYTHEMA (redness), DIZZINESS (dizziness) and FATIGUE (tiredness) had not resolved and BRAIN FOG (had brain fog), HEAD DISCOMFORT (alike an unclear head) and DYSSTASIA (difficult to stand) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported. It is unknown when her most recent dose was or how many doses she had received. She was unsure if her most recent dose was a monovalent or bivalent product. Since she had the last shot she had brain fog. This is alike an unclear head. It's very hard to get rid of if at all. Had a problem with dizziness regularly that had been ongoing since before the vaccine. The dizziness coupled with the brain fog can make it difficult to stand. Drinking ginger dissolved in boiling water seems to help with the brain fog. She had also been having some issues with tiredness and redness. She was told prior to receiving her most recent vaccine she should not receive it because of her continued dizziness symptoms. She received this dose anyways. She just spoke with her pharmacist who was concerned that her symptoms had lasted so long. Unknown how long after receiving this dose symptoms started. Unknown how long symptoms had been ongoing. She never had covid. History of rheumatic fever.
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site eczema, Injection site erythema, Injection site swelling
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: eczema looking patch at injection site. size of a quarter-Medium, Additional Details: patient developed a round ezema looking patch the size of a quarted at the injection site. He developed 2 other ezcema looking areas, one below the injection site on the left arm and one near the elbow on the right arm. Patient indicates he will be reaching out to prescriber about the reactions.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Joint injury, Limb injury, Pain, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Contraindication to vaccination, Injection site bruising, Injection site pain
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Error: Known Immunization Allergy Contraindication-
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angina unstable, Cardiac stress test abnormal, Chest discomfort, Chest pain, Echocardiogram
Clinical narrative: Patient is a 66 y.o. female who presents with chest pain.  Patient was transferred from emergency department for further evaluation and management of unstable angina.  The patient initially presented there with sudden, onset severe intermittent dull pressure-like left sided chest pain with radiation to her left arm that started 2 days prior to admission.  She reported that the chest pain was intermittent in nature, noting that the episodes of chest pain would last about an hour at a time.  She further explained that she would have these intermittent episodes of chest pain roughly 3 to 4 times a day, with her last episode occurring while she was present in the ED prior to transfer.  When EMS arrived, the patient was diaphoretic and experiencing severe chest pain.  EMS administered 324 mg Aspirin at this time, of which provided the patient little relief.  She initially rated her chest pain a 8-10/10 at its onset, but rated the pain a 7/10 upon arrival to the hospital.  She was placed on 3L NC O2 while in the ED, of which was weaned down to 2L upon transfer to Facility.  She received several doses of sublingual nitroglycerin that provided some relief.  Upon my evaluation here, the patient denied any shortness of breath and mentioned that her chest pain has improved.  She reported that laying down flat and resting helped relieve her symptoms.  She denied experiencing anything like this before.  Denied any nausea, vomiting, or abdominal pain.  Patient denied any history of cardiac stents, heart failure, heart attacks, ulcers, bloody stools, or a significant family history of cardiac issues.  She also noted that she does wear 3.5L NC O2 at baseline.   During the hospital stay, chest pain resolved, ACS was ruled out.  Serial troponins were negative and Lexiscan stress test was negative.  After a 3 days hospital stay, patient was discharged to a swing bed unit for ongoing PT/OT.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ejection fraction, Hyperhidrosis, Left ventricular hypertrophy, Mitral valve incompetence, Pain
Clinical narrative: Patient is a 66 y.o. female who presents with chest pain.  Patient was transferred from emergency department for further evaluation and management of unstable angina.  The patient initially presented there with sudden, onset severe intermittent dull pressure-like left sided chest pain with radiation to her left arm that started 2 days prior to admission.  She reported that the chest pain was intermittent in nature, noting that the episodes of chest pain would last about an hour at a time.  She further explained that she would have these intermittent episodes of chest pain roughly 3 to 4 times a day, with her last episode occurring while she was present in the ED prior to transfer.  When EMS arrived, the patient was diaphoretic and experiencing severe chest pain.  EMS administered 324 mg Aspirin at this time, of which provided the patient little relief.  She initially rated her chest pain a 8-10/10 at its onset, but rated the pain a 7/10 upon arrival to the hospital.  She was placed on 3L NC O2 while in the ED, of which was weaned down to 2L upon transfer to Facility.  She received several doses of sublingual nitroglycerin that provided some relief.  Upon my evaluation here, the patient denied any shortness of breath and mentioned that her chest pain has improved.  She reported that laying down flat and resting helped relieve her symptoms.  She denied experiencing anything like this before.  Denied any nausea, vomiting, or abdominal pain.  Patient denied any history of cardiac stents, heart failure, heart attacks, ulcers, bloody stools, or a significant family history of cardiac issues.  She also noted that she does wear 3.5L NC O2 at baseline.   During the hospital stay, chest pain resolved, ACS was ruled out.  Serial troponins were negative and Lexiscan stress test was negative.  After a 3 days hospital stay, patient was discharged to a swing bed unit for ongoing PT/OT.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Troponin normal, Ventricular enlargement, Wall motion score index
Clinical narrative: Patient is a 66 y.o. female who presents with chest pain.  Patient was transferred from emergency department for further evaluation and management of unstable angina.  The patient initially presented there with sudden, onset severe intermittent dull pressure-like left sided chest pain with radiation to her left arm that started 2 days prior to admission.  She reported that the chest pain was intermittent in nature, noting that the episodes of chest pain would last about an hour at a time.  She further explained that she would have these intermittent episodes of chest pain roughly 3 to 4 times a day, with her last episode occurring while she was present in the ED prior to transfer.  When EMS arrived, the patient was diaphoretic and experiencing severe chest pain.  EMS administered 324 mg Aspirin at this time, of which provided the patient little relief.  She initially rated her chest pain a 8-10/10 at its onset, but rated the pain a 7/10 upon arrival to the hospital.  She was placed on 3L NC O2 while in the ED, of which was weaned down to 2L upon transfer to Facility.  She received several doses of sublingual nitroglycerin that provided some relief.  Upon my evaluation here, the patient denied any shortness of breath and mentioned that her chest pain has improved.  She reported that laying down flat and resting helped relieve her symptoms.  She denied experiencing anything like this before.  Denied any nausea, vomiting, or abdominal pain.  Patient denied any history of cardiac stents, heart failure, heart attacks, ulcers, bloody stools, or a significant family history of cardiac issues.  She also noted that she does wear 3.5L NC O2 at baseline.   During the hospital stay, chest pain resolved, ACS was ruled out.  Serial troponins were negative and Lexiscan stress test was negative.  After a 3 days hospital stay, patient was discharged to a swing bed unit for ongoing PT/OT.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema
Clinical narrative: ANGIOEDEMA, INIT
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ischaemic stroke
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Angina unstable, Symptom recurrence
Clinical narrative: UNSTABLE ANGINA 11/16/2022 &  12/19/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Laboratory test, Muscle spasms
Clinical narrative: I was at a nonprofit meeting in the evening and I felt a cramp in my left leg. And I walked off the cramp but upon sitting down again I felt another cramp and the next thing I knew I was on the floor. And my next memory was an EMT at the meeting was asking questions i.e.; what year it was, who was the President was. The EMT took my vitals and everything was fine. I was told and at the point I called my husband no emergency help was called. I had mowed the yard that day and my doctor and I felt it was dehydration but I have been referred to a Cardiologist and that appointment is 01JUN2023.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 2/21/2023 -- RECURRENCE OF SAME SYMPTOMS
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: ACUTE MI
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: It was found that the vaccine was improperly stored upon arrival to the facility. No adverse events happened to patient.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Neuropathy peripheral, Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA NEUROPATHY
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: It was found that the vaccine was improperly stored upon arrival to the facility. No adverse events happened to patient.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Hospitalized with covid; fully vaccinated with 2 boosters. Pt. expired.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: hospitalized with covid; fully vaccinated with 2 boosters
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Extra dose administered
Clinical narrative: Patient also received Kinrix at the same time. Received two doses of DTaP.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, INIT NEUROPATHY
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Angina pectoris, Symptom recurrence
Clinical narrative: STABLE ANGINA ACUTE ST ELEVATION MI, UNSPECIFIED 3/6/2023 -- RECURRENCE OF SAME SYMPTOMS
Age: 64.0
Sex: F
Vaccine: UNK
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, patient was given an expired dose.
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, the patient received and expired dose of vaccine
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism, Shock
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE PULMONARY EMBOLISM SHOCK, UNSPECIFIED
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Feeling cold, Headache, Influenza B virus test positive, Malaise
Clinical narrative: I went outside 18APR2023 and felt the effects of pollen immediately in my throat. That day and the days that followed I had congestion, headache, sneezing, I never had fever but chills and body aches so I stayed in the house due to not feeling well, I took my temperature but no fever. My symptoms began to worsen then and they lasted about three weeks, I took three COVID-19 tests all negative. 25APR2023 I thought I had a sinus infection and so I saw my doctor and was administered a tripple test which resulted in a positive Flu B. I was freezing with a chills after that and was prescribed TAMIFLU by my doctor, a seven day course. I was feeling better in a few days and back to normal.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Respiratory tract congestion, SARS-CoV-2 test negative, Sneezing
Clinical narrative: I went outside 18APR2023 and felt the effects of pollen immediately in my throat. That day and the days that followed I had congestion, headache, sneezing, I never had fever but chills and body aches so I stayed in the house due to not feeling well, I took my temperature but no fever. My symptoms began to worsen then and they lasted about three weeks, I took three COVID-19 tests all negative. 25APR2023 I thought I had a sinus infection and so I saw my doctor and was administered a tripple test which resulted in a positive Flu B. I was freezing with a chills after that and was prescribed TAMIFLU by my doctor, a seven day course. I was feeling better in a few days and back to normal.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Epilepsy, Hypotension
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE EPILEPSY, UNSPECIFIED HYPOTENSION
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Vertigo
Clinical narrative: Sudden onset of vertigo with headache; saw a DPT with expertise in treatment of vertigo; saw her on the third day and it was fixed
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute coronary syndrome, Acute myocardial infarction, Chronic respiratory failure, Obstructive sleep apnoea syndrome, Respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA ACUTE NON ST ELEVATION MI ACUTE CORONARY SYNDROME, UNSPECIFIED CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Polyneuropathy, Symptom recurrence
Clinical narrative: DRUG INDUCED POLYNEUROPATHY 6/19/2022,  11/8/2022,  11/30/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Pneumonia
Clinical narrative: Pfizer vaccine was administered  - reported by patient- NO LOT NUMBER WERE SUPPLIED ACUTE RESPIRATORY FAILURE 11/18/2022 POST OBSTRUCTIVE PNEUMONIA
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product preparation error
Clinical narrative: Patient received 0.2mL of undiluted vaccine.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Hypotension, Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: OBSTRUCTIVE SLEEP APNEA ACUTE ST ELEVATION MI, ANTERIOR WALL ACUTE ST ELEVATION MI, UNSPECIFIED HYPOTENSION 9/7/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 0.58
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: bivalent booster as a primary series shot.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Aortic aneurysm, Respiratory failure
Clinical narrative: Moderna vaccine was administered outside of our facility- reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------ J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/6/2022 ABDOMINAL AORTIC ANEURYSM 4.0-4.4 CM J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 10/11/2022 ABDOMINAL AORTIC ANEURYSM 4.0-4.4 CM
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 0.33
Sex: F
Vaccine: DTPPVHBHPB, PNC13, RV5, DTPPVHBHPB, PNC13, RV5
Symptoms: Pyrexia, Vomiting
Clinical narrative: Fever and vomiting
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatic mass, Hypovolaemic shock
Clinical narrative: R57.1 HYPOVOLEMIC SHOCK 10/6/2022 LIVER MASS
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Affective disorder, Hypoxia
Clinical narrative: HYPOXIA 11/5/2022 MOOD DISORDER, UNSPECIFIED TYPE HYPOXIA 11/5/2022 MOOD DISORDER, UNSPECIFIED TYPE
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI 8/10/2022 &  2/13/2023 -- RECURRENCE OF SAME SYMPTOMS
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Hypotension, Sepsis
Clinical narrative: I95.9 HYPOTENSION 10/10/2022 ABDOMINAL PAIN I95.9 HYPOTENSION 10/10/2022 SEPSIS WO ACUTE ORGAN DYSFUNCTION I95.9 HYPOTENSION 10/10/2022 DIARRHEA I95.9 HYPOTENSION 10/10/2022 SEPSIS WO ACUTE ORGAN DYSFUNCTION
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines ; Moderna 4/16/21 Lot# 030A21A  Moderna 3/25/22 lot# 022J21A;  Moderna 2/2/23 Lot# 010H22A
Age: 11.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Patient was given a dose of Meningitis B vaccine (TruMenba) instead of Meningitis ACWY vaccine (MenActra). Spoke with Mom and informed her of the situation. Patient will receive 1 dose of Meningitis ACWY vaccine at next well visit (12 y/o) and will still need 2 doses of Meningitis B vaccine at 18 y/o well visit.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Angina pectoris, Coronary artery disease, Muscle spasms
Clinical narrative: I21.4 ACUTE NON ST ELEVATION MI 11/29/2022 ACUTE NON ST ELEVATION MI I21.4 ACUTE NON ST ELEVATION MI 11/29/2022 ACUTE NON ST ELEVATION MI CAD W ANGINA AND SPASM
Age: 57.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines  Moderna 3/16/21 lot# 044A21A;  Moderna 4/13/21 Lot# 025B21A;  moderna 12/13/21 lot# 031H21A;  Moderna 7/13/22 lot# 058A22-2A; Moderna 11/7/22 lot# 062F22A
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE DVT, UNSPECIFIED VEIN 3/19/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 12/24/20 lot# 026L20A;  Moderna 1/19/21 lot# 012L20A
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Facial paralysis, Haemophilus infection, Sepsis
Clinical narrative: G51.0 RIGHT FACIAL PALSY 2/16/2022 SEPSIS DUE TO HEMOPHILUS INFLUENZAE
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 65.0
Sex: M
Vaccine: FLU4, PNC13
Symptoms: Injection site pain, X-ray limb
Clinical narrative: Patient reports pain at injection site that started a few hours after receiving vaccine.  He presumed it was normal soreness from the vaccine but the pain did not improve.  The pain has worsened over time.  He has intermittent sharp stabbing pain at the injection site that was occurring weekly but it is now occurring daily.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Cognitive disorder
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 11/26/2022 COGNITIVE DISORDER
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 1/5/2022  -- RECURRENCE OF SAME SYMPTOMS
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Ophthalmic migraine, Visual impairment
Clinical narrative: When I first started getting the ocular migraines, I thought they I had a brain tumor. They were occurring only once a month so I would not say anything to my doctor because I was afraid, I would have to have brain surgery and I was having the vison problems with it. The headaches then started coming more frequently, I went in to see my doctor about the frequent headaches. I mentioned the migraines to him with the visual problems. He then told me I was having ocular migraines.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Bronchitis, COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease
Clinical narrative: HAD BRONCHITITS TESTED NEGATIVE FOR COVID 1-27-23 AND ADMITTED  WITH PNEUMONIA LIKE SX AND COPD EXACERBATION TO LOCAL HOSPITAL . HE PRESENTED AGAIN  2-14-23 WITH SHORTNESS OF BREATH FOR 5-6 DAYS  ,REQUIRED CPAP AND BIPAP IN ER  ADMITTED WITH ACUTE RESP FAILURE WITH HYPOXIA  , PNEUMONIA AND COVID.     DECEASED AT HOSPICE 3-12-23
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Dyspnoea, Pneumonia, Positive airway pressure therapy
Clinical narrative: HAD BRONCHITITS TESTED NEGATIVE FOR COVID 1-27-23 AND ADMITTED  WITH PNEUMONIA LIKE SX AND COPD EXACERBATION TO LOCAL HOSPITAL . HE PRESENTED AGAIN  2-14-23 WITH SHORTNESS OF BREATH FOR 5-6 DAYS  ,REQUIRED CPAP AND BIPAP IN ER  ADMITTED WITH ACUTE RESP FAILURE WITH HYPOXIA  , PNEUMONIA AND COVID.     DECEASED AT HOSPICE 3-12-23
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: HAD BRONCHITITS TESTED NEGATIVE FOR COVID 1-27-23 AND ADMITTED  WITH PNEUMONIA LIKE SX AND COPD EXACERBATION TO LOCAL HOSPITAL . HE PRESENTED AGAIN  2-14-23 WITH SHORTNESS OF BREATH FOR 5-6 DAYS  ,REQUIRED CPAP AND BIPAP IN ER  ADMITTED WITH ACUTE RESP FAILURE WITH HYPOXIA  , PNEUMONIA AND COVID.     DECEASED AT HOSPICE 3-12-23
Age: 27.0
Sex: F
Vaccine: HEP
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pediatric  dose given when an adult dose was needed. No adverse reaction was noted.
Age: 16.0
Sex: M
Vaccine: MENB
Symptoms: Peripheral swelling
Clinical narrative: Patient's mother called the office stating patient's arm was swollen. Denied redness or rash.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Received Covid Bivalent booster as 2nd dose in primary series.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Condition aggravated, Coronary artery disease, Death
Clinical narrative: had recent cad which could not be stented.  to er 4-25-23 and admitted with pneumonia, covid, cad, sepsis, ischemic cardiomyopathy deceased 5-9-23
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Ischaemic cardiomyopathy, Pneumonia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: had recent cad which could not be stented.  to er 4-25-23 and admitted with pneumonia, covid, cad, sepsis, ischemic cardiomyopathy deceased 5-9-23
Age: 12.0
Sex: M
Vaccine: MENB
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: There was no true adverse event. The vaccine was given in error due to the child only being 12 and having no special considerations for receiving the vaccine before the age of 16.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE 1/25/2022  --  RECURRENCE OF SAME SYMPTOMS
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Angina pectoris, Myocardial infarction
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE STABLE ANGINA ACUTE ST ELEVATION MI, ANTEROSEPTAL ACUTE NON ST ELEVATION MI
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE HYPOXIA 7/27/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: I95.89 CHRONIC HYPOTENSION 10/12/2022 HX OF TRANSIENT ISCHEMIA ATTACK I95.9 HYPOTENSION 9/25/2022 HX OF TRANSIENT ISCHEMIA ATTACK
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Rash
Clinical narrative: Unsure if Vaccine related but 2 weeks after Patient received his booster a rash developed.  He had no other reactions from prior vaccines received. It would get better with OTC hydrocortisone cream but then within days would come back in various part of his body.  Review of his meds were completed and the current meds he is on are those he has been on since admission.  Facility had not changed cleaning products or laundry products.  Family had not changed any body washes or colognes or changed any of his food preferences.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac failure acute, Chronic respiratory failure, Left ventricular failure, Respiratory failure
Clinical narrative: Moderna vaccine was administered outside of Facility- reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------------------ J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/18/2022 SYSTOLIC HEART FAILURE, ACUTE ON CHRONIC
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: HOSP-HOSPITAL 9/18/2022  10/18/2022 HOSP-HOSP 7/23/2022  8/8/2022
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Arteriovenous fistula operation, Hypotension, Vascular access malfunction
Clinical narrative: Pfizer vaccine was administered outside of clinic- reported by patient- ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------------------------  HYPOTENSION 11/22/2022 SURGICAL ARTERIOVENOUS FISTULA MALFUNCTION, INIT
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Generalised tonic-clonic seizure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE GENERALIZED CONVULSIVE EPILEPSY
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Respiratory failure
Clinical narrative: ACUTE HYPERCAPNIC RESPIRATORY FAILURE 9/3/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Femur fracture, Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM 11/10/2022 LEFT FEMUR FX INIT ACUTE PULMONARY EMBOLISM 11/10/2022 ACUTE PULMONARY EMBOLISM
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Angina unstable, Symptom recurrence
Clinical narrative: UNSTABLE ANGINA STABLE ANGINA 10/17/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 63.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Chills, Fatigue, Pyrexia, Salivary gland mucocoele
Clinical narrative: I had a fever, fatigue and chills for about two days after receiving the vaccine.  In 12/2022, I developed an oral mucocele on the left side.  I wrote to my primary doctor, and I was referred to an ENT.  I saw my dentist and she suspected a mucocele. At this time, I have no pain, so we are waiting and watching.